<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> Cellular Microbiology (2014) 16(5), 642&#226;&#8364;&#8220;656                                                                        doi:10.1111/cmi.12287 <br />                                                                                                     published online 27 March 2014 <br />  <br />  <br />  <br /> Conditional expression apical membrane antigen 1 Plasmodium falciparum shows required erythrocyte invasion merozoites <br />  <br /> Alan Yap,1 Mauro F. Azevedo,2 Paul R. Gilson,2                           lethal species infect humans (Snow et al., <br /> Greta E. Weiss,2 Matthew T. O&#226;&#8364;&#8482;Neill,1                                    2005), Plasmodium vivax gaining importance <br /> Danny W. Wilson,1 Brendan S. Crabb2                                  major cause malaria mortality morbidity <br /> Alan F. Cowman1*                                                         outside Africa (Guerra et al., 2010). Plasmodium para- <br /> 1 <br />  Walter Eliza Hall Institute Medical                          sites passage mosquito vector human <br /> Research, Melbourne, Vic. 3052, Australia.                               host complete multi-stage development, adopting <br /> 2 <br />  Macfarlane Burnet Institute Medical Research <span id='am-12' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-13' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span>amp</span>;                      multiple invasive &#226;&#8364;&#732;zoite&#226;&#8364;&#8482; forms process. Public Health, Melbourne, Vic. 3004, Australia.                          humans, sporozoites injected skin female <br />                                                                          Anopheles mosquitoes infected malaria                                                                          rapidly invade hepatocytes initiate liver stage infec- <br />  Summary <br />                                                                          tion. intracellular parasites develop exoeryth- <br />  Malaria caused obligate intracellular para-                       rocytic merozoites released bloodstream <br />  sites, Plasmodium falciparum                            invade circulating erythrocytes. obligate <br />  lethal species. humans, P. falciparum                           intracellular parasites, merozoites mature erythro- <br />  merozoites (invasive forms parasite) employ                      cytes develop cyclically ring, trophozoite <br />  host parasite proteins rapidly invade eryth-                    schizont stages inside compartment termed  rocytes. P. falciparum apical                       parasitophorous vacuole. final stage deve- <br />  membrane antigen 1 (PfAMA1) forms                               lopment, parasite undergoes asexual division <br />  complex rhoptry neck proteins tight                         (schizogony) produce 16&#226;&#8364;&#8220;32 daughter merozoites  junction.  placed Pfama1 gene                          released egress invade new erythrocytes. <br />  conditional control using dimerizable                                Invasion erythrocytes merozoites complex <br />  Cre recombinase (DiCre) P. falciparum. DiCre-                        multistep process (reviewed Cowman Crabb, <br />  mediated excision loxP-flanked Pfama1 gene                       2006). egress infected erythrocyte bursts releasing <br />  results approximately 80% decreased expres-                          merozoites attach uninfected erythrocytes.  sion protein intraerythrocytic                        low potassium level bloodstream triggers intracel- <br />  growth cycle. reduces growth 40%,                        lular calcium release activating sequential release  decreased invasion efficiency characterized                        micronemes rhoptries, apical secretory <br />  post-invasion defect sealing parasit-                         organelles secrete proteins involved invasion <br />  ophorous vacuole. results                               process (Singh et al., 2010). attached eryth- <br />  PfAMA1 essential protein merozoite inva-                      rocyte, merozoite reorientates apical end  sion P. falciparum directly indi-                      erythrocyte surface interface forms  rectly plays role resealing red blood cell                  cells; tight junction composed parasite proteins <br />  posterior end invasion event.                             periphery merozoite apex cross- <br />                                                                          sectional plane invasion. Active invasion ensues                                                                          merozoite slides tight junction, moves <br /> Introduction                                                             anterior posterior end parasite cell. Malaria, caused Plasmodium parasites,                        merozoite penetrates erythrocyte, proteins lipids <br /> remains major public health problem large parts                  released apical organelles pocket formed <br /> sub-Saharan Africa, tropical subtropical regions                  primarily invaginating erythrocyte membrane <br /> Asia Americas. Plasmodium falciparum                      (Suss-Toby et al., 1996; Gruring et al., 2011; Riglar et al., <br />                                                                          2011). merozoite completely entered <br />                                                                          erythrocyte, membrane closed forming Received 23 December, 2013; revised 23 February, 2014; accepted <br /> 24 February, 2014.  correspondence. E-mail cowman@                   parasitophorous vacuole sealing erythrocyte <br /> wehi.edu.au; Tel. (+61) 393 452 555; Fax (+61) 393 470 852.              membrane. takes place, erythrocyte <br />  <br /> &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  open access article terms Creative Commons Attribution-NonCommercial License, permits use, distribution reproduction medium, provided original work properly cited used commercial purposes. <br />  <br />                                                                                                                 cellular microbiology <br />                                                                                            Conditional expression PfAMA1     643 <br />  <br /> undergoes 5&#226;&#8364;&#8220;10 min echinocytosis (transient spike-                   complex contains RON4 RON5 (Alexander <br /> like extrusions erythrocyte membrane possibly                    et al., 2005; Collins et al., 2009; Riglar et al., 2011). caused dehydration) infected erythrocyte                  RON complex appears released merozo- <br /> reverts normal shape (Gilson Crabb, 2009).                ite&#226;&#8364;&#8482;s rhoptry organelles prior penetration embeds time, merozoite differentiated amoe-               erythrocyte surface serves attachment <br /> boid ring-stage parasite (Gruring et al., 2011; Riglar et al.,          point AMA1 (Lamarque et al., 2011). <br /> 2011).                                                                     lines evidence support AMA1&#226;&#8364;&#8220;RON2 <br />    Apical membrane antigen 1 number                      model tight junction. AMA1&#226;&#8364;&#8220;RON2 interaction <br /> proteins released parasite micronemes,                  disrupted small peptides RON2L, type integral membrane protein synthesized seg-               competes native RON2 protein leads menting schizonts 83 kDa precursor protein.                       inhibition merozoite invasion (Srinivasan et al., 2011b). AMA1 secreted merozoite surface prior                  AMA1-binding monoclonal antibodies inhibit merozoite schizont rupture prodomain cleaved leaving                  invasion blocking AMA1&#226;&#8364;&#8220;RON2 interaction. Addi- <br /> 66 kDa membrane-bound species (Crewther et al., 1990;                   tionally, <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="peptide" datatype="xsd:string"></span>peptide</span> R1 (Harris et al., 2005) mimics Narum Thomas, 1994; Howell et al., 2001). AMA1                      structure AMA1-binding region RON2 homologues exist apicomplexan parasites                         result blocks merozoite invasion formation tight <br /> including Plasmodium species sequenced <span id='am-11' about='oboInOwl:date' typeof='owl:Thing'>date</span>,                     junction (Vulliez-Le Normand et al., 2012). <br /> Toxoplasma gondii Babesia divergens (Donahue                            experiments using AMA1 knockout et al., 2000; Montero et al., 2009). ectodomains                 knockdown mutants P. berghei merozoites AMA1 Plasmodium share similar tertiary structure                   T. gondii tachyzoites suggested AMA1 plays suggesting conserved role (Bai et al., 2005). Paradoxi-               role tight junction formation important, cally, AMA1 highly polymorphic protein                   essential, host cell attachment (Giovannini et al., <br /> variation approximately 10% amino acids                       2011; Bargieri et al., 2013). Additionally, investiga- <br /> (Chesne-Seck et al., 2005). sequence poly-                        tors showed AMA1 required merozoite rep- <br /> morphisms contribute antibody escape                   lication erythrocyte reduced <br /> fore major hurdle generating effective AMA1                     multiplication rate observed approximately 35% <br /> vaccine (Healer et al., 2004). Nonetheless, AMA1                   reflects defect merozoite entry host cell <br /> leading blood stage vaccine candidate evidence                     (Bargieri et al., 2013). <br /> showing protection clinical malaria early                  dimerizable Cre recombinase (DiCre) technology <br /> field trials (Thera et al., 2011).                                      (Jullien et al., 2003) adapted P. falciparum <br />    Despite importance merozoite invasion, bio-              related apicomplexan parasite T. gondii logical function PfAMA1 remained largely unknown                     provide rapid efficient method gene deletion recently. Early genetic studies T. gondii suggest            conditional expression (Andenmatten et al., 2013; <br /> role AMA1 invasion host cells. Viable TgAMA1                  Collins et al., 2013). Using DiCre technology knockout mutants obtained (Hehl et al.,                    constructed P. falciparum parasite expression <br /> 2000) conditional knockout mutants TgAMA1                   PfAMA1 protein conditional control result- <br /> severely impaired host cell invasion (Mital et al., 2005).           ing knockdown protein expression approximately gene encoding PfAMA1 disrupted                      80% single intraerytrocytic growth cycle. results <br /> asexual blood stages P. falciparum species              inhibition merozoite invasion provides evidence <br /> Plasmodium suggesting essential (Triglia et al.,                 PfAMA1 required successful invasion 2000; Giovannini et al., 2011; Bargieri et al., 2013).                  erythrocytes. highly studied aspect AMA1  <br /> mation tight junction, feature initially <br /> observed electron-dense region point                    Results <br /> contact invading merozoite erythro- <br />                                                                         Conditional regulation PfAMA1 <br /> cyte (Aikawa et al., 1978). tight junction thought serve anchor parasite                      gene encoding PfAMA1 refractory genetic abla- <br /> actomyosin motor provides traction needed                       tion conventional knockout strategies (Triglia et al., <br /> merozoites pull itself erythrocyte (Tyler               2000) consequently constructed P. falciparum <br /> Boothroyd, 2011; Bargieri et al., 2012). interaction                line placed conditional regulation. PfAMA1 parasite protein called                      simultaneously disrupted endogenous <br /> rhoptry neck protein 2 (RON2) essential tight junc-              Pfama1 gene, W2mef line single recombination, <br /> tion formation, commits merozoite invasion                plasmid pAMA1-loxP allowing complementation <br /> (Srinivasan et al., 2011b). RON2 larger RON                transfected gene (encodes antigenically distinct <br />  <br /> &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />   644  Yap et al. <br />  <br />  <br />  <br />  <br /> Fig. 1. Schematic sequential generation W2mef/AMA1-loxP W2mef/AMA1-loxP/DiCre parasites. transfection, gene Pfama1 W2mef genetically disrupted complemented codon-altered 3D7 Pfama1 gene using pAMA1-loxP <br /> plasmid. main features pAMA1-loxP homologous target sequence recombination followed W2mef promoter sequence &#226;&#8364;&#732;floxed&#226;&#8364;&#8482; 3D7 Pfama1 gene. hdhfr selectable drug cassette, confers resistance antifolate WR99210, used select transfectants. Homologous integration tandemly arranged pAMA1-loxP plasmids W2mef AMA1 locus resulted duplication 3D7 Pfama1 gene. architecture modified locus shown AflIII NdeI restriction sites used Southern blot <br /> analysis. Sizes digested DNA fragments shown kilobase (kb). W2mef/AMA1-loxP parasites cloned limiting dilution. second transfection, DiCre introduced W2mef/AMA1-loxP clone using pDiCre plasmid. expression casette pDiCre shown boxed insert  right). N- C-terminus fragments Cre recombinase driven bi-directional P. berghei EF1&#206;&#177; <br /> promoter hsp86 promoter respectively Cre fusions placed head tail orientation. Transcription termination modulated 3&#226;&#8364;&#178; UTR sequences P. berghei dihydrofolate reductase-thymidylate synthase (DT 3&#226;&#8364;&#178;) P. falciparum calmodulin (CAM 3&#226;&#8364;&#178;) genes. DiCre  Cre recombinase fused F2 linker FKBP12 FRB sequence induce dimerization presence <span id='am-6' about='obo:IMR_0002818' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-7' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:id" content="IMR:0002818" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="rapamycin" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="KEGG:C07909" datatype="xsd:string"></span>rapamycin</span>. included Gal4 nuclear localization signal target DiCre fusion proteins nucleus expressed bsd <br /> resistance marker, confers resistance blasticidin. predicted modification Pfama1 locus following DiCre-mediated Pfama1 <br /> excision shown restriction digest sizes. <br />  <br />  <br />  <br /> 3D7 allele) flanked loxP sites (Fig. 1). resulting               tive Cre fragments occur FK506-binding protein <br /> W2mef/AMA1-loxP parasites cloned limiting dilu-                   (FKBP12) FKBP12-rapamycin-binding (FRB) domain <br /> tion clones derived copies plasmid                 FRAP (FKBP12-rapamycin-associated protein) (Jullien <br /> inserted Pfama1 gene resulting functional                 et al., 2003). Southern blot analysis W2mef/AMA1- <br /> copies 3D7 allele (Figs 1 2A, Fig. S1).                        loxP/DiCre parasites confirmed pDiCre plasmid <br />    second step transfected plasmid pDiCre,                  present (Fig. 2B) endogenous Pfama1 gene encodes conditionally dimerizable halves                    disrupted expected (Fig. 2A). W2mef/ Cre recombinase, W2mef/AMA1-loxP derive                        AMA1-loxP/DiCre clones generated (referred W2mef/AMA1-loxP/DiCre (Fig. 1). Normally, DiCre                       2F9 B4) used subsequent analyses. 2F9 <br /> enzyme inactive unable recombine loxP                     B4 transgenic parasites exhibited normal growth rate <br /> sites excise Pfama1. Cre recombinase activated                  suggesting deleterious effect DiCre presence rapamycin association inac-                 expression absence rapamycin (data shown). <br />  <br />                            &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />                                                                                              Conditional expression PfAMA1           645 <br />  <br />  <br />  <br />  <br /> Fig. 2. W2mef/AMA1-loxP W2mef/AMA1-loxP/DiCre parasites complemented 3D7 AMA1 protein.  Southern blot indicates copies pAMA1-loxP integrated W2mef Pfama1 locus leading duplication heterologous 3D7 Pfama1 gene. 4 3 kb AflIII fragments indicate second copy length integrated plasmid  Fig. 1). 4 3 kb signals equal intensity Southern blot, indicating copy numbers identical  e. 1:1 ratio). 1.45 kb signal signifies 3&#226;&#8364;&#178; end modified locus second plasmid joins endogenous, disrupted W2mef Pfama1 gene. signal single copy fragment used DNA loading control track. <br /> B. Southern blotting using XhoI restriction enzyme confirms presence 9.3 kb length pDiCre plasmid W2mef/AMA1-loxP/DiCre <br /> parasites. <br /> C. Immunoblot analysis late-schizont extracts probed specific anti-3D7 AMA1 mAb 3A2 showing abundant forms AMA1: 83 kilodalton (kDa) precursor, AMA183 66 kDa processed form, AMA166. result shows complementation 3D7 <br /> AMA1 protein occurred W2mef/AMA1-loxP W2mef/AMA1-loxP/DiCre clonal lines (2F9 B4). <br /> D. polyclonal PfAMA1 antibody detected PfAMA1 signals tracks including parental W2mef confirming result previous <br /> immunoblot. <br /> E. Parental transgenic parasites grown media +/&#226;&#710;&#8217; R1 peptide. R1 peptide binds specifically 3D7 PfAMA1 W2mef <br /> PfAMA1. Complementation W2mef/AMA1-loxP/DiCre parasites functional 3D7 PfAMA1 protein evident R1 peptide significantly <br /> inhibited growth 3D7, 2F9 B4 parasites W2mef (n = 2 experiments triplicate). Error bars indicate standard <br /> deviation (SD). <br />  <br />  <br />  <br /> W2mef/AMA1-loxP W2mef/AMA1-loxP/DiCre                                 confirmed immunoblot analysis late-stage schizont <br /> parasites express functional heterologous 3D7                           stages using monoclonal antibody specific 3D7 <br /> AMA1 protein                                                              PfAMA1 ectodomain PfAMA1 rabbit polyclonal anti- <br />                                                                           body. Anti-3D7 AMA1 recognized length pro- <br /> Previously, generated transgenic P. falciparum                    cessed forms AMA1 (AMA183 AMA166) W2mef/ <br /> expressing heterologous Pfama1 alleles differ sus-                AMA1-loxP, 2F9 B4 lines W2mef parental <br /> ceptibility invasion inhibitory antibodies (Healer et al.,             lines (Fig. 2C). contrast, polyclonal PfAMA1 anti- <br /> 2004). use strategy disrupt endog-                 body detected protein transgenic parental lines <br /> enous Pfama1 gene W2mef simultaneously                           showing W2mef/AMA1-loxP W2mef/AMA1-loxP/ <br /> complementing loss function antigenically                     DiCre parasites expressed 3D7 AMA1 allele <br /> distinct 3D7 Pfama1 allele (Fig. 1). Complementation                  (Fig. 2D). <br />  <br /> &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />   646  Yap et al. <br />  <br />    3D7 allele PfAMA1 expressed               Excision Pfama1 results decreased transgenic lines functional tested ability           PfAMA1 expression 20-residue peptide, R1, inhibit merozoite inva- <br />                                                                     Pfama1 gene excision B4 2F9 <br /> sion erythrocytes (Harris et al., 2005). R1 <br />                                                                     populations 70&#226;&#8364;&#8220;92% deter- <br /> peptide strain-specific recognizes 3D7 AMA1                                                                     mined corresponding level PfAMA1 protein expres- low affinity W2mef AMA1. carried                                                                     sion Cre recombinase activity induced flow cytometry (FACS)-based growth assay incubat- <br />                                                                     rapamycin. Schizont-stage parasites analysed ing 3D7, W2mef, 2F9 B4 parasites R1 peptide. <br />                                                                     immunoblot using &#206;&#177;-3D7 AMA1 antibody. presence R1, 3D7 parasite growth inhib- <br />                                                                     approximately 81% knockdown AMA1 protein levels <br /> ited approximately 80% W2mef parasites                                                                     time points compared untreated affected (Fig. 2E). contrast, growth 2F9                                                                     parasites (Fig. 4A&#226;&#8364;&#8220;C). Expression invasion pro- <br /> B4 expressed 3D7 PfAMA1 inhibited                                                                     teins PfRh4, RON4 EBA175 unaffected <br /> 90&#226;&#8364;&#8220;95% presence R1 consistent                                                                     (Fig. 4D). level PfAMA1 protein knockdown corre- <br /> transgenic parasites expressing functional 3D7 AMA1 <br />                                                                     lated level Pfama1 gene excision mediated protein (Fig. 2E). <br />                                                                     DiCre. <br />                                                                        determined level PfAMA1 protein <br /> DiCre-mediated excision PfAMA1 gene                          expression using immunomicroscopy untreated                                                                     rapamycin-treated late stage schizonts. Parasites determine efficiency DiCre-mediated excision <br />                                                                     treated rapamycin DMSO 48 h. revealed inserted Pfama1 genes, determined                                                                     gradient PfAMA1 signal intensities ranging high target effect rapamycin parasite growth (Fig. <br />                                                                     levels detectable PfAMA1 conditions <br /> S2A&#226;&#8364;&#8220;C). Accordingly, used rapamycin 0.1                                                                     (Fig. 4E). Parasites treated rapamycin dis- <br /> 0.2 &#206;&#188;M subsequent experiments W2mef                                                                     played variation PfAMA1 signal intensity depend- <br /> W2mef/AMA1-loxP parasites grew normally                                                                     ent maturity schizonts (data shown). concentrations.  B4 2F9 parasites syn- <br />                                                                     impartially determine rapamycin treatment resulted chronized incubated 0.1% DMSO                                                                     reduced PfAMA1 expression, average pixel intensity <br /> 0.1 &#206;&#188;M rapamycin 48, 96, 144 192 h. Genomic <br />                                                                     70 pixel diameter region encompassing DNA extracted parasites analysed                                                                     schizonts measured. parasites positive Southern blot determine level DiCre-mediated <br />                                                                     schizont-stage marker merozoite surface protein 1 (MSP1) <br /> excision Pfama1. single-copy 3.7 kb band corre- <br />                                                                     counted timing MSP1 protein expres- <br /> sponding 3&#226;&#8364;&#178; end plasmid pAMA1-loxP <br />                                                                     sion activated just PfAMA1 (PlasmoDB, <br /> crossover used loading control (Figs 1 3A). <br />                                                                     http://plasmodb.org/plasmo). histogram pixel <br /> Rapamycin-induced excision Pfama1 demon- <br />                                                                     intensities confirmed rapamycin treatment resulted strated shift band 9.3 kb 7.4 kb.                                                                     half strongly staining AMA1-positive <br /> percentage excision varied 70% 92%                                                                     parasites (+ rapamycin: 21 parasites; &#226;&#710;&#8217; rapamycin: 56 <br /> quantified densitometry B4 2F9 parasites <br />                                                                     parasites) medium weakly staining parasites 48 h rapamycin (Fig. 3B C).                                                                     (+ rapamycin: 103 parasites; &#226;&#710;&#8217; rapamycin: 68 parasites) <br /> subsequent time points, excision Pfama1                                                                     (Fig. 4F). 124 schizonts observed, 83% medium extent approximately 80% B4                                                                     weakly staining AMA1-positive parasites rapamycin <br /> 2F9 parasites. lack additive effect terms                                                                     treatment group compared 55% non-treated group. excision rate unexpected continuous <br />                                                                     shift decreased PfAMA1 staining following <br /> expression DiCre result Pfama1 <br />                                                                     rapamycin treatment suggests deletion Pfama1 genes deleted. likely                                                                     directly contributing reduction PfAMA1. Microscopy expression DiCre activity sufficient excise <br />                                                                     schizonts reduced PfAMA1 showed Pfama1 copies single intraerythrocytic growth <br />                                                                     merozoite microneme organelles particular <br /> cycle approximately 20% expressed sufficient <br />                                                                     parasite cell evenly stained indicating extent <br /> protein invade survive. <br />                                                                     PfAMA1 knockdown uniform daughter <br />    determined DiCre activity                                                                     merozoites (Fig. 4E). <br /> detected intraerythrocytic growth cycle Southern blot analysis. Excision Pfama1                                                                     AMA1 knockdown leads growth inhibition detected 30 h post incubation rapamycin (Fig. 3D <br />                                                                     W2mef/AMA1-loxP/DiCre parasites E). consistent EF1&#206;&#177; bi-directional <br /> promoter active ring-stage parasite         determine knockdown PfAMA1 induced DiCre <br /> life cycle (Fig. 1).                                                expression affected parasite growth invasion,  <br />                        &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />                                                                                                Conditional expression PfAMA1             647 <br />  <br />  <br />  <br />  <br /> Fig. 3. Efficient DiCre-mediated deletion Pfama1 cycle intraerythrocytic growth.  Representative Southern blots showing efficient DiCre-mediated excision Pfama1 clones B4   2F9   time <br /> points corresponding intraerythrocytic growth cycle. Highly synchronized ring-stage parasites split dishes. Half treated 0.1 &#206;&#188;M rapamycin (Rap) remaining dishes treated 0.1% DMSO vehicle control. Genomic DNA extracted treatment pair (Rap DMSO) 48, 96, 144 192 h parasites late-schizont stage. Southern <br /> blotting genomic DNA digested NdeI detected fragments track. intact Pfama1 gene represented &#226;&#8364;&#732;non-excised&#226;&#8364;&#8482; 9.3 kb fragment deletion Pfama1 gene represented &#226;&#8364;&#732;excised&#226;&#8364;&#8482; 7.4 kb fragment. additional 3.7 kb fragment <br /> corresponds single-copy 3&#226;&#8364;&#178; end pAMA1-loxP integration event acts measure DNA loading track. time <br /> point, rapamycin treatment resulted higher proportion &#226;&#8364;&#732;excised&#226;&#8364;&#8482; fragments compared DMSO treatment, showed non-existential background DNA recombination (n = 2). <br /> B. Densitometric quantification reveals Pfama1 excision rate ranges 70&#226;&#8364;&#8220;92% time point B4 parasites. determined ratio intensity &#226;&#8364;&#732;excised&#226;&#8364;&#8482; fragment total intensity (&#226;&#8364;&#732;excised&#226;&#8364;&#8482; &#226;&#8364;&#732;non-excised&#226;&#8364;&#8482; fragments) track, normalized DNA loading (n = 2). Error bars indicate SD. <br /> C. Similar analysis 2F9 parasites results equally efficient excision Pfama1 (n = 2). Error bars indicate SD. <br /> D. Southern blot time-course 2F9 parasites reveals &#226;&#8364;&#732;excised&#226;&#8364;&#8482; fragment detected 30 h addition rapamycin. <br /> DiCre-mediated excision Pfama1 occurs mid late trophozoite stage. <br /> E. Densitometric analysis Southern blot time-course indicates significant increase Pfama1 deletion occurred 15 30 h post rapamycin treatment. <br />  <br />  <br /> measured ability W2mef/AMA1-loxP/DiCre cloned                        growth relative untreated parasites (Fig. 5D E). <br /> parasite lines (2F9 B4) multiply presence                  results showed PfAMA1 required rapamycin. 2F9 B4 parasites showed reduc-                        normal growth P. falciparum. <br /> tion growth dose-dependent manner maximum <br /> reduction 40% 72 h (Fig. 5A B). monitored <br />                                                                             PfAMA1 required invasion erythrocytes <br /> growth rapamycin-treated W2mef/AMA1-loxP/DiCre <br />                                                                             merozoites <br /> parasites intraerythrocytic development non-rapamycin treated para-                     showed PfAMA1 function P. falciparum sites supporting idea loss PfAMA1 function                  required growth. determine affecting merozoite invasion (Fig. S3A). Furthermore,                       essential role invasion, purified merozoites 2F9 parasite growth monitored extended periods                          B4 parasites tested ability invade eryth- rapamycin treatment. Rapamycin treatment                       rocytes (Boyle et al., 2010). PfAMA1 protein knockdown <br /> effect W2mef/AMA1-loxP parasites, lack DiCre                       purified merozoites confirmed immunoblot <br /> expression (Fig. 5C). contrast, rapamycin-treated                        analysis showed expressed 60&#226;&#8364;&#8220;80% protein <br /> W2mef/AMA1-loxP/DiCre parasites greatly reduced                         following rapamycin treatment (data shown).  <br /> &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />   648  Yap et al. <br />  <br />  <br />  <br />  <br /> Fig. 4. Rapamycin strongly specifically depletes PfAMA1 expression late stage parasites.  Representative immunoblots significantly decreased PfAMA1 expression following rapamycin treatment B4  panels) 2F9  panels) parasites time points. monoclonal antibody specific 3D7 AMA1 used, detected unprocessed 83 kDa processed 66 kDa PfAMA1. Anti-HSP70 used loading control. <br /> B C. using densitometry quantification, PfAMA1 knockdown estimated average 81% parasite lines time points (n = 2). Error bars indicate SD. <br /> D. Immunoblot analysis indicates expression rhoptry micronemal proteins PfRh4, PfRON4 PfEBA175 reduced rapamycin treatment. <br /> E. Schizonts rapamycin-treated parasites dual labelled anti-MSP1 (red) anti-PfAMA1 (green) reduction PfAMA1 <br /> expression. Schizonts displaying gradient high (arrow, row), medium  row) low (arrowhead, row) levels PfAMA1 <br /> expression observed. Scale bar 5 &#206;&#188;m. <br /> F. Histogram pixel brightness PfAMA1 antibody-labelled parasites, categorized groups: strong, medium weak  <br /> Average pixel intensity PfAMA1 measured 70 pixel diameter surrounding parasite MSP1-positive schizont stages selected. <br />  <br />  <br />  <br />  <br /> independent experiments cloned lines 2F9 B4,                    Real time imaging rapamycin-treated <br /> rapamycin-mediated PfAMA1 knockdown resulted                         W2mef/AMA1-loxP/DiCre merozoites shows merozoite invasion 43&#226;&#8364;&#8220;85% untreated control                  reduced ability invade <br /> (Fig. 5F). average, merozoites invaded 37% effectively following rapamycin treatment 48 h                      Rapamycin-induced Pfama1 deletion resulted signifi- <br /> (Fig. 5G) agreement growth inhi-               reduction merozoite invasion used real <br /> bition rate determined previously. PfAMA1                  time imaging investigate mechanistic defect. Live <br /> required invasion P. falciparum merozoites                  W2mef/AMA1-loxP/DiCre parasites imaged erythrocytes.                                                           normal growth conditions following treatment  <br />                           &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />                                                                                            Conditional expression PfAMA1            649 <br />                                                                                              Fig. 5. PfAMA1 knockdown leads                                                                                              substantial growth inhibition decreased <br />                                                                                              merozoite invasion. <br />                                                                                              B. FACS-based growth assays                                                                                              dose-dependent growth inhibition 2F9                                                                                              B4 parasites presence rapamycin.                                                                                              0.1 &#206;&#188;M rapamycin (non-inhibitory wild type <br />                                                                                              growth), DiCre-mediated knockdown                                                                                              PfAMA1 resulted 40% growth inhibition <br />                                                                                              (n = 3; triplicate experiments). Error bars <br />                                                                                              indicate SD. <br />                                                                                              C. Rapamycin does affect <br />                                                                                              W2mef/AMA1-loxP parasite growth                                                                                              DMSO- rapamycin-treated parasites <br />                                                                                              expanded normally. Arrows denote splitting                                                                                              parasites (n = 2; triplicate experiments).                                                                                              representative experiment shown. Error <br />                                                                                              bars indicate SD. <br />                                                                                              D E. B4 2F9 parasites expand <br />                                                                                              normally course week                                                                                              rapamycin-mediated PfAMA1 knockdown. <br />                                                                                              DMSO-treated parasites grew normally                                                                                              parasitemia recorded days <br />                                                                                              (n = 2 triplicate). representative <br />                                                                                              experiment shown similar results                                                                                              obtained 2F9 parasites. Error bars indicate <br />                                                                                              SD. <br />                                                                                              F. Rapamycin-mediated PfAMA1 knockdown <br />                                                                                              results reduced merozoite invasion                                                                                              erythrocytes. Invasion assays performed <br />                                                                                              using purified merozoites incubated                                                                                              0.1 &#206;&#188;M rapamycin 0.1% DMSO v/v. <br />                                                                                              independent experiments, <br />                                                                                              rapamycin-treated 2F9 B4 merozoites <br />                                                                                              invaded 43&#226;&#8364;&#8220;85% DMSO-treated <br />                                                                                              merozoites. <br />                                                                                              G. average, rapamycin treatment leads                                                                                              37% invasion inhibition 2F9 B4 <br />                                                                                              merozoites (n = 4; triplicate experiments). <br />                                                                                              Error bars indicate SD. <br />  <br />  <br />  <br />  rapamycin. Late-stage schizonts imaged                  observed untreated merozoites 35 appeared success- <br /> time-lapse microscopy periods 15&#226;&#8364;&#8220;30 min. Follow-                 ful 3 failed (Fig. 6D). failed invasions <br /> ing schizont rupture, untreated W2mef/AMA1-loxP para-                   merozoite deformed erythrocyte, triggered sites merozoites behaved similarly wild type merozoites              echinocytosis failed penetrate remained contacted erythrocytes deformed                attached outside erythrocyte. target cells seconds penetration                     failed invasions merozoites penetrated, triggered <br /> (Fig. 6A) (Gilson Crabb, 2009). Invasion itself lasted              echinocytosis reversed invasion site <br /> approximately 10 s erythrocyte underwent                outside erythrocyte. <br /> echinocytosis 30&#226;&#8364;&#8220;60 s later. Echinocytosis appears                   Following rapamycin treatment knockdown caused dehydration host cell (Tiffert et al., 2005)           PfAMA1 expression proportion merozoites failing took average 376 s recovery.                   productively invade transform ring stage para- <br /> recovery process merozoite observed trans-                 site increased approximately 40% (Fig. 6D). forming amoeboid ring stage parasite (Gruring                   merozoites failed invade fell groups:  <br /> et al., 2011; Riglar et al., 2011). 38 attempted invasions           failed penetrate, caused echinocytosis  <br /> &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />   650  Yap et al. <br />                                                                                          Fig. 6. Rapamycin induction DiCre results <br />                                                                                          increased merozoites invade <br />                                                                                          erythrocytes. <br />                                                                                           Selected images video <br />                                                                                          sequence showing untreated merozoite <br />                                                                                          (arrow) successfully invading erythrocyte <br />                                                                                          (Type invasion). Time shown minutes <br />                                                                                          seconds. <br />                                                                                          B. Rapamycin-treated merozoite (arrow)                                                                                          deforms invade target <br />                                                                                          erythrocyte. merozoite triggers <br />                                                                                          echinocytosis remains attached                                                                                          target erythrocyte (arrowheads) (Type II <br />                                                                                          invasion). <br />                                                                                          C. Rapamycin-treated merozoite (arrow)                                                                                          penetrates fails reseal target <br />                                                                                          erythrocyte does develop                                                                                          ring-stage parasite (Type III invasion). <br />                                                                                          D. ratio successful invasion (Type  <br />                                                                                          versus unsuccessful invasion (Type II III) <br />                                                                                          decreases presence rapamycin <br />                                                                                          (P = 0.0052, Fisher&#226;&#8364;&#8482;s exact test). <br />                                                                                          E. Rapamycin treatment results greater <br />                                                                                          percentage failed invasion events.                                                                                          60% failed invasion events                                                                                          prolonged echinocytosis (EC) periods                                                                                          &gt; 500 s (s). Note total number                                                                                          events (n) +/&#226;&#710;&#8217; Rap D <br />                                                                                          E echinocytosis period                                                                                          ascertained invasion event. <br />  <br />  <br />  <br />  <br /> remained attached (Fig. 6B) second, pen-             proven possible permanently delete gene encoding <br /> etrated, triggered echinocytosis failed produce            AMA1 range Plasmodium species (Triglia et al., <br /> ring (Fig. 6C). group merozoites exited          2000; Bargieri et al., 2013). gene disruption penetration whilst remained internal.          proved impossible, studies using transgenic complemen- failed invasions target erythrocyte remained          tation approaches inhibition endogenous PfAMA1 <br /> echinocyte greatly extended period compared              using R1 peptide successful (Healer et al., <br /> successful invasions suggesting failure reseal             2004; Drew et al., 2012). provided erythrocyte surface following penetration attempted              test function PfAMA1 inserting specific muta- <br /> penetration (Fig. 6E). case successful inva-          tions added additional evidence sions generally echinocytosis period               protein required merozoite invasion (Leykauf et al., 500 s (Fig. 6E). 60% failed invasion              2010).  data reported study shows events rapamycin-treated merozoites character-             blood-stage growth substantially impeded, probably <br /> ized echinocytosis periods 500 s consistent            prevented altogether, absence AMA1. idea defect resealing                  Mechanistically, known AMA1 binds invaded erythrocyte (Fig. 6E).                                      parasite-encoded protein RON2 parasite <br />                                                                     complex injected host cell membrane pre- <br />                                                                     invasion stage functioning erythrocyte- <br /> Discussion <br />                                                                     surface receptor (Besteiro et al., 2009; Cao et al., 2009; <br /> AMA1 intensely studied apicomplexan              Richard et al., 2010; Lamarque et al., 2011; Tonkin et al., <br /> ligands data strongly implied obligatory            2011; Tyler Boothroyd, 2011).  invasion <br /> role protein invasion Plasmodium                 P. falciparum merozoites PfAMA1 observed <br /> merozoites host erythrocytes. Notably, despite efforts         forming ring surface moves tight numerous groups using different systems,              junction RON complex consistent  <br />                        &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />                                                                                                   Conditional expression PfAMA1             651 <br />  <br />  <br />  <br />  <br /> Fig. 7. Model showing role AMA1 merozoite invasion erythrocytes. AMA1 implicated initial stages merozoite <br /> invasion, including rhoptry secretion erythrocytes, tight junction formation (Riglar et al., 2011) possibly apical reorientation (Mitchell <br /> et al., 2004) recently refuted (Srinivasan et al., 2011a). tight junction serves anchor myosin-dependent penetration merozoite (Gonzalez et al., 2009). penetration step coincides formation parasitophorous vacuole (PV) rhoptry contents 5&#226;&#8364;&#8220;10 min period echinocytosis. merozoite completed entry, PV pinches erythrocyte membrane, erythrocyte seals reverts normal shape (Gilson Crabb, 2009). <br /> Expression AMA1 excess wild type parasites level AMA1 reduces, efficient sealing erythrocyte <br /> membrane occurs. shown prolonged echinocytosis sufficient AMA1 form penetrative tight junction sealing tight junction. reduction AMA1 leads inability form tight junction merozoite remains attached penetrate erythrocyte. <br />  <br />  <br />  <br />  <br /> binding directly RON complex playing                               imperfect nature genetic deletion event using <br /> essential role process (Riglar et al., 2011). Using                   (&#226;&#710;&#188; 80%), fact timing dele- <br /> different agents (antibodies peptides) block                         tion post-DNA replication  recombinase AMA1&#226;&#8364;&#8220;RON2 interaction, data gener-                          control trophozoite-stage promoter) means <br /> ated Plasmodium merozoites Toxoplasma                             schizonts include mixture tachyzoites suggests interaction absolutely                      merozoites genetically null wild type required establishment tight junction                      Pfama1 gene. circumstances predicted essential invasion (Hehl et al., 2000; Harris                    PfAMA1 protein synthesized schizonts <br /> et al., 2005; Richard et al., 2010; Lamarque et al., 2011;                    distributed evenly merozoites Riglar et al., 2011; Srinivasan et al., 2011b). data                    microneme biogenesis precedes parasite segmentation. course consistent inability disrupt                     IFA data consistent AMA1 <br /> Plasmodium ama1 gene circumstances require                         staining merozoites schizonts ranged <br /> parasite maintenance blood-stage culture.                                  brightness dull bright.     Given data described  surprising                     genetic deletion 80%, merozoites deletion ama1 gene, using conditional FLP/FRT                      rapamycin population range AMA1 levels rodent malaria parasite P. berghei, sug-                         low close normal  Fig. 7). <br /> gested AMA1 essential tight-junction                        PfAMA1-deficient merozoite population unable <br /> mation invasion (Bargieri et al., 2013).                        invade erythrocytes effectively wild type para-  uncertainty remains function AMA1,                        sites. Real time imaging merozoite invasion shown <br /> especially role invasion erythrocytes Plas-                  &#226;&#8364;&#732;non-invaders&#226;&#8364;&#8482; adhere erythrocyte <br /> modium merozoites. paper, sought                        cause characteristic deformations precede acti- <br /> address issue employing different conditional                           vation invasion. similar invasion pheno- using vitro cultured P. falciparum parasites.                   type observed following treatment R1 peptide placed Pfama1 conditional control                                 (Leykauf et al., 2010). Occupation AMA1&#226;&#8364;&#8482;s RON2 <br /> P. falciparum merozoites using DiCre allelic                           binding pocket R1 peptide prevents tight junction <br /> replacement strategy allows excision functional                   formation echinocytosis, event probably <br /> gene concordantly decreased PfAMA1 expression                          triggered rhoptry release occurring independently parasite population.                                                      tight junction formation permeabilizing erythrocyte <br />  <br /> &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />   652  Yap et al. <br />  <br /> surface (Gilson Crabb, 2009). phenotypic               Experimental procedures <br /> similarity R1 treatment suggests rapamycin- <br />                                                                       Cloning DNA constructs <br /> treated merozoites failed penetrate host cell <br /> probably small amounts PfAMA1                    Table S1 contains list primers used study. pAMA1- <br /> expression (Fig. 7). Conversely, rapamycin-treated                loxP generated modifying pCC1AMA1TP.1, interme- <br /> merozoites penetrate target erythrocytes prob-             diate construct previous study (Drew et al., 2012). <br />                                                                       pCC1AMA1TP.1 contained W2mef Pfama1 target <br /> ably PfAMA1 form tight junction. <br />                                                                       sequence W2mef Pfama1 promoter. length, codon-  merozoites failed seal erythrocyte <br />                                                                       optimized 3D7 Pfama1 sequence flanked pair loxP sites  cases exit inva-               arranged direct repeats synthesized Life Technologies <br /> sion pocket, probably lack sufficient PfAMA1 enable            (USA). 3D7 Pfama1 synthetic fragment subsequently <br /> tight junction operate efficiently pinch                cloned pCC1AMA1TP.1 using KpnI PstI produce parasitophorous vacuole reseal erythrocyte                    final construct, pAMA1-loxP. DiCre components (boxed <br /> plasma membrane (Fig. 7).                                             insert Fig. 1) synthesized Life Technologies (USA).                                                                       nuclear localization signal (NLS) comprising 74 residues <br />    Interestingly, half rapamycin-treated merozoites <br />                                                                       yeast Gal4 (Wittayacom et al., 2010) included successfully invaded greatly extended <br />                                                                       N-terminal region component. component 1 (C1), NLS <br /> echinocytosis periods consistent parasites                 followed FKBP12, F2 spacer residues 19&#226;&#8364;&#8220;59 Cre <br /> having efficient tight junction. implies             recombinase (Jullien et al., 2003). C1 flanked XhoI/PstI <br /> PfAMA1 excess normal parasites               restriction sites. Component 2 (C2) composed NLS, FRB, F2 <br /> level reduced efficient resealing occurs.            spacer residues 60&#226;&#8364;&#8220;343 Cre recombinase. C2 flanked <br /> PfAMA1 levels reduced threshold penetra-                XmaI/SpeI restriction sites. vector express DiCre <br />                                                                       components based pEF-Luc-GFP-DD29  tive tight junction formed organization                                                                       Azevedo et al., 2012). selectable marker hDHFR insufficient resealing erythrocyte. reduc- <br />                                                                       replaced blasticidin S-deaminase (BSD), tion PfAMA1 leads tight junction formation               retrieved pCC4 (Maier et al., 2008), digested penetration.                                             BamHI/HindIII cloned pEF-Luc-GFP-DD29 generating <br />    mentioned  separate study Bargieri                pEF-Luc-GFP-DD29-BSD. P. berghei hDHFR 3&#226;&#8364;&#178; UTR (DT 3&#226;&#8364;&#178;) et al. conditional ama1 gene knockout mutants               PCR amplified pCC1 (Maier et al., 2008) primers <br /> obtained P. berghei T. gondii using conditional              F-PbDT3-Pst R-PbDT3-Mlu (Table S1), digested PstI/ <br />                                                                       MluI cloned pEF-Luc-GFP-DD29-BSD, generating pEF- <br /> FLP/FRT (Bargieri et al., 2013). orthologues <br />                                                                       Luc-DT3. C1 cloned XhoI/PstI sites pEF-Luc-DT3, paralogues AMA1 identified                                                                       generating pEF-C1-DT3. Heat shock protein 86 promoter <br /> function absence Plasmodium sporozoites (e.g.               (HSP86 5&#226;&#8364;&#178;) PCR amplified pCC1 (Maier et al., 2008) <br /> MAEBL) T. gondii tachyzoites (Poukchanski et al.,                  primers F-HSP86-Mlu R-HSP86-Xma, digested 2013) obvious candidates expressed Plas-              MluI/XmaI cloned pEF-C1-DT3, generating pEF-C1-DT3- <br /> modium merozoites complement AMA1 function                   HSP. C2 digested XmaI/SpeI cloned pEF-C1- stage life cycle. merozoites         DT3-HSP, generating final construct pDiCre (Fig. 1). invade despite having detectable AMA1 authors concluded AMA1 essential tight               Parasite cultures transfections <br /> junction formation invasion (Bargieri et al., 2013),                                                                       Asexual blood stage cultures P. falciparum 3D7 W2mef <br /> contrast data paper.  pos-             clones maintained human O+ erythrocytes using standard <br /> sible interpretation data P. berghei           conditions (Maier et al., 2008). use human erythrocytes merozoites possess small amounts AMA1 protein;                 parasite culturing approved Walter Eliza Hall incomplete gene excision given hepatic                    Human Research Ethics Committee (ethics number 86/17) schizont.  respect Plasmodium merozoite                 Australian Red Cross Blood Service Agreement (11-09VIC- <br />                                                                       01). Transfection W2mef parasites described (Crabb <br /> invasion erythrocytes, possible results                                                                       et al., 2004). Briefly, synchronized ring-stage parasites 5&#226;&#8364;&#8220;8% study Bargieri et al. consistent <br />                                                                       parasitemia electroporated 100 &#206;&#188;g plasmid. Stable <br /> (Bargieri et al., 2013).                                              transformants W2mef/AMA1-loxP selected    conclusion, data adds direct functional evidence            antifolate drug, WR99210 (2.5 nM). Transfection W2mef/ strong existing case AMA1                  AMA1-loxP parasites pDiCre performed using essential Plasmodium merozoite invasion               Nucleofector&#194;&#174; Technology (Lonza) (Janse et al., 2006). Mature <br /> operates promoting tight-junction formation func-              schizonts isolated synchronized culture using 60% <br />                                                                       Percoll solution (GE Healthcare). Purified schizonts tioning.  intermediate levels AMA1 expres- <br />                                                                       transfected electroporation 50 &#206;&#188;g pDiCre using Amaxa <br /> sion merozoite mutants revealed <br />                                                                       Nucleofactor&#194;&#174; device (Lonza), Basic Parasite Nucleofactor&#194;&#174; Kit 1 role AMA1 sealing tight-                 (Lonza) program U33. W2mef/AMA1-loxP/DiCre parasites <br /> junction following invasion. clearly requires              selected using blasticidin (2.5 &#206;&#188;g ml&#226;&#710;&#8217;1, Invitrogen) cul- investigation.                                                   tured shaking incubator improve parasite growth post <br />  <br />                          &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />                                                                                            Conditional expression PfAMA1            653 <br /> transfection (Allen Kirk, 2010). W2mef/AMA1-loxP/               2F9 B4 (typical culture volume 200 ml  &gt; 5% <br /> DiCre clones, 2F9 B4, isolated limiting dilution        parasitemia 2&#226;&#8364;&#8220;3% haematocrit) split grown used subsequent analyses.                                           0.1 &#206;&#188;M rapamycin 0.1% DMSO v/v late <br />                                                                         schizonts. Schizonts isolated uninfected erythrocytes <br />                                                                         MAC magnet separation column (Macs; Miltenyi Biotech). <br /> Induction DNA recombination                                          Purified schizonts incubated 10 &#206;&#188;M cysteine <br /> Rapamycin obtained LC Laboratories (USA)                   protease inhibitor E64 prevent schizont ruptures. 5&#226;&#8364;&#8220;6 h solubilized DMSO 2.73 mM. induce dimerization DiCre,        incubation, schizont pellets passaged 1.2 &#206;&#188;m <br /> 0.1 0.2 &#206;&#188;M rapamycin added W2mef/AMA1-loxP/DiCre              syringe filter (Acrodisc; 32 mm; Pall). Filtrate containing purified <br /> clones final concentration 0.1% DMSO cases.            merozoites plated triplicates (10 &#206;&#188;l  topped <br />                                                                         media total 50 &#206;&#188;l) addition 0.5% uninfected <br />                                                                         erythrocytes. Plates agitated 10 min. cycle <br /> DNA analysis Southern blot                                           parasites progressed mature trophozoite-stage, <br />                                                                         parasitemia assessed flow cytometry described earlier. <br /> Parasite genomic DNA isolated using standard phenol/                Remaining purified merozoites used assay chloroform extraction methods (Sambrook et al., 1989).              pelleted solubilized SDS sample buffer Western blot <br /> digoxigenin (DIG)-labelled probes synthesized using PCR            analysis.  purified merozoites retrospectively quantified <br /> DIG Probe Synthesis Kit (Roche). W2mef Pfama1 targeting             using CountBright&#194;&#174; absolute counting beads (Life Technologies) <br /> sequence probe amplified primers mo493 mo492               ensure number purified merozoites added using pAMA1-loxP plasmid template (Table S1). bsd         start invasion assays rapamycin <br /> probe, pDiCe plasmid used PCR template            treament DMSO treatment. <br /> primers aw317 aw318 (Table S1). Southern blots                     alternative method used measuring invasion inhi- <br /> genomic DNA digested completion AflIII  pAMA1-          bition following multiple cycles growth presence loxP integration analysis), NdeI  Pfama1 excision analysis)      rapamycin. 250 &#206;&#188;l sorbitol-synchronized, ring-stage 2F9 clone <br /> XhoI  verify presence pDiCre), separated 0.8%       cultured 96 microtitre plate 1% hematocrit. <br /> agarose gel transferred Hybond N + nylon membrane (GE            Samples plated triplicate treated DMSO Healthcare). Detection performed using DIG Easy Hyb             rapamycin. 50 &#206;&#188;l samples removed, fixed <br /> kit (Roche) according manufacturer&#226;&#8364;&#8482;s protocol. Quantification        0.25% glutaraldehyde 1&#195;&#8212; phosphate buffered saline (PBS) Southern blot signals performed using Quantity           incubated 100 &#206;&#188;l SYBR Green (Invitrogen) 1-D Analysis Software (Bio-Rad).                                        15 min. Cells finally resuspended PBS flow cytometry. <br />                                                                         Samples collected day 0 day 7 sample <br /> Immunoblot                                                              24 h apart. Initial gating carried wild type 3D7 <br />                                                                         parasites comparing Giemsa smears, method <br /> Synchronous mature schizonts harvested suspended               accurately distinguishes ring-stage late-stage parasites. 0.15% saponin. Saponin pellet solubilized SDS sample <br /> buffer separated SDS-PAGE. Immunoblots AMA1 analysed using monoclonal antibody (mAb) 3A2, specifi-            Microscopy <br /> cally recognizes 3D7 AMA1. antibodies used study <br /> include rabbit polyclonal AMA1 antibody R190, polyclonal anti-        Air-dried smears infected erythrocytes fixed ice-cold <br /> body EBA-175 R1179, PfRh4 mAb 2E8 mAb               methanol 5 min blocked 1 h PBS 1% <br /> PfRON4. Anti-HSP70 polyclonal antibody used loading              casein. Parasites probed rabbit polyclonal IgG control.                                                                MSP1&#226;&#8364;&#8220;19 (60 &#206;&#188;g ml&#226;&#710;&#8217;1) mouse monoclonal IgG PfAMA1 <br />                                                                         (2H4, 100 &#206;&#188;g ml&#226;&#710;&#8217;1) blocking buffer 1 h. briefly washing <br />                                                                         twice PBS 0.05% Tween 20 PBS, para- <br /> Intracellular parasite growth assay                                     sites probed goat anti-rabbit Alexa 568 anti-mouse <br />                                                                         Alexa 488  1 2000, Invitrogen) 1 h. washing Parasite growth assays performed previously described <br />                                                                          parasites mounted Vectashield DAPI <br /> (Wilson et al., 2010). Synchronized ring-stage parasites                                                                         (Vector). Images taken Zeiss AxioObserver 100&#195;&#8212; <br /> plated triplicates (50 &#206;&#188;l) 1% parasitemia 1% haemato- <br />                                                                         oil lens manipulated ImageJ. measuring PfAMA1 <br /> crit. Rapamycin DMSO added 1 10 dilution                                                                         intensity images captured exposure time <br /> assess growth inhibition cycle intraerythrocytic <br />                                                                         adjusted minimum maximum threshold <br /> growth. Parasites cultured 72 h cycle <br />                                                                         settings 160 2012 respectively. 70-pixel diameter circle parasites progressed mature trophozoites. Para- <br />                                                                         drawn schizont minimum, average sites stained 10 &#206;&#188;g ml&#226;&#710;&#8217;1 ethidium bromide (EtBr; Bio- <br />                                                                         maximum pixel intensities acquired ImageJ manipu- <br /> Rad) hour parasitemia assessed flow <br />                                                                         lated Microsoft Excel Prism (Graphpad Software). <br /> cytometry. R1 peptide growth assay used protocol R1 peptide added 100 &#206;&#188;g ml&#226;&#710;&#8217;1. <br />  <br />                                                                         Real-time imaging <br /> Merozoite invasion inhibition assay <br />                                                                         Late stage W2mef/AMA1-loxP/DiCre (2F9 B4) schizonts <br /> Merozoites purified based established method (Boyle          (2 ml) 0.16% hematocrit settled 35 mm Fluorodish <br /> et al., 2010). Highly synchronized ring-stage parasite clones        (World Precision Instruments) imaged inverted Zeiss <br />  <br /> &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />   654  Yap et al. <br /> AxioObserver microscope brightfield. sample chamber             Boyle, M.J., Wilson, D.W., Richards, J.S., Riglar, D.T., Tetteh, heated 37&#194;&#176;C supplied humidified 1% <span id='am-24' about='obo:IMR_0200217' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="O2" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:id" content="IMR:0200217" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasDbXref" content="KEGG:C00007" datatype="xsd:string"></span>O2</span>, 5%              K.K., Conway, D.J., et al. (2010) Isolation viable <br /> <span id='am-19' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-20' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="CO2" datatype="xsd:string"></span>CO2</span> 94% N2 atmosphere.                                               Plasmodium falciparum merozoites define eryth- <br />                                                                          rocyte invasion events advance vaccine Acknowledgements                                                         drug development. Proc Natl Acad Sci USA 107: 14378&#226;&#8364;&#8220; <br />                                                                          14383. thank Red Cross Blood Service (Melbourne, Australia)        Cao, J., Kaneko, O., Thongkukiatkul, , Tachibana, M., <br /> supply red blood cells serum Walter            Otsuki, H., Gao, Q., et al. (2009) Rhoptry neck protein <br /> Eliza Hall Institute Medical Research Monoclonal Laboratory           RON2 forms complex microneme protein AMA1 growing monoclonal antibodies. work supported           Plasmodium falciparum merozoites. Parasitol Int 58: National Health Medical Research Council Australia         29&#226;&#8364;&#8220;35. <br /> (NHMRC) (637406), Victorian State Government Opera-            Chesne-Seck, M.L., Pizarro, J.C., Vulliez-Le Normand, B., <br /> tional Infrastructure Support grant. Y. recipient PhD          Collins, C.R., Blackman, M.J., Faber, B.W., et al. (2005) <br /> scholarships Walter Eliza Hall Institute Medical         Structural comparison apical membrane antigen 1 <br /> Research University Melbourne (Australia).             orthologues paralogues apicomplexan parasites. F.C. Howard Hughes International Scholar. thank                Mol Biochem Parasitol 144: 55&#226;&#8364;&#8220;67. <br /> Nicholas Lim assistance SYBR Green-based invasion         Collins, C.R., Withers-Martinez, C., Hackett, F., assays.                                                                  Blackman, M.J. (2009) inhibitory antibody blocks inter- <br />                                                                          actions components malarial invasion <br />                                                                          machinery. PLoS Pathog 5: e1000273. <br /> References                                                             Collins, C.R., Das, S., Wong, E.H., Andenmatten, N., <br /> Aikawa, M., Miller, L.H., Johnson, J., Rabbege, J. (1978)            Stallmach, R., Hackett, F., et al. (2013) Robust inducible <br />   Erythrocyte entry malarial parasites. moving junction             Cre recombinase activity human malaria parasite <br />   erythrocyte parasite. J Cell Biol 77: 72&#226;&#8364;&#8220;82.               Plasmodium falciparum enables efficient gene deletion <br /> Alexander, D.L., Mital, J., Ward, G.E., Bradley, P.,                 single asexual erythrocytic growth cycle. Mol <br />   Boothroyd, J.C. (2005) Identification moving junction           Microbiol 88: 687&#226;&#8364;&#8220;701. <br />   complex Toxoplasma gondii: collaboration                Cowman, F., Crabb, B.S. (2006) Invasion red blood <br />   distinct secretory organelles. PLoS Pathog 1: e17.                     cells malaria parasites. Cell 124: 755&#226;&#8364;&#8220;766. <br /> Allen, R.J., Kirk, K. (2010) Plasmodium falciparum                 Crabb, B.S., Rug, M., Gilberger, T.W., Thompson, J.K., <br />   culture: benefits shaking. Mol Biochem Parasitol                Triglia, T., Maier, G., Cowman, F. (2004) <br />   169: 63&#226;&#8364;&#8220;65.                                                            Transfection human malaria parasite Plasmodium <br /> Andenmatten, N., Egarter, S., Jackson, J., Jullien, N.,                falciparum. Methods Mol Biol 270: 263&#226;&#8364;&#8220;276. <br />   Herman, J.P., Meissner, M. (2013) Conditional                    Crewther, P.E., Culvenor, J.G., Silva, , Cooper, J ,   genome engineering Toxoplasma gondii uncovers alter-                Anders, R.F. (1990) Plasmodium falciparum: antigens <br />   native invasion mechanisms. Nat Methods 10: 125&#226;&#8364;&#8220;127.                   similar size located different compartments Azevedo, M.F., Gilson, P.R., Gabriel, H.B., Simoes, R.F.,             rhoptry. Exp Parasitol 70: 193&#226;&#8364;&#8220;206. <br />   Angrisano, F., Baum, J., et al. (2012) Systematic analysis           Donahue, C.G., Carruthers, V.B., Gilk, S.D., Ward, G.E. <br />   FKBP inducible degradation domain tagging strategies                (2000) Toxoplasma homolog Plasmodium apical <br />   human malaria parasite Plasmodium falciparum.                  membrane antigen-1 (AMA-1) microneme protein <br />   PLoS 7: e40981.                                                    secreted response elevated intracellular calcium <br /> Bai, T., Becker, M., Gupta, , Strike, P., Murphy, V.J.,                levels. Mol Biochem Parasitol 111: 15&#226;&#8364;&#8220;30. <br />   Anders, R.F., Batchelor, H. (2005) Structure                Drew, D.R., Hodder, N., Wilson, D.W., Foley, M., Mueller, <br />   AMA1 Plasmodium falciparum reveals clustering                , Siba, P.M., et al. (2012) Defining antigenic diversity <br />   polymorphisms surround conserved hydrophobic                    Plasmodium falciparum apical membrane antigen 1   pocket. Proc Natl Acad Sci USA 102: 12736&#226;&#8364;&#8220;12741.                       requirements multi-allele vaccine malaria. <br /> Bargieri, D., Lagal, V., Tardieux, , Menard, R. (2012)             PLoS 7: e51023. <br />   Host cell invasion apicomplexans: know?                Gilson, P.R., Crabb, B.S. (2009) Morphology kinetics <br />   Trends Parasitol 28: 131&#226;&#8364;&#8220;135.                                          distinct phases red blood cell invasion Bargieri, D.Y., Andenmatten, N., Lagal, V., Thiberge, S.,                Plasmodium falciparum merozoites. Int J Parasitol 39: <br />   Whitelaw, J , Tardieux, , et al. (2013) Apical membrane            91&#226;&#8364;&#8220;96. <br />   antigen 1 mediates apicomplexan parasite attachment              Giovannini, D., Spath, S., Lacroix, C., Perazzi, , Bargieri, <br />   dispensable host cell invasion. Nat Commun 4: 2552.             D., Lagal, V., et al. (2011) Independent roles apical <br /> Bell, , Wernli, B., Franklin, R.M. (1994) Roles                 membrane antigen 1 rhoptry neck proteins host <br />   peptidyl-prolyl cis-trans isomerase calcineurin             cell invasion apicomplexa. Cell Host Microbe 10: 591&#226;&#8364;&#8220; <br />   mechanisms antimalarial action cyclosporin  FK506,             602. <br />   rapamycin. Biochem Pharmacol 48: 495&#226;&#8364;&#8220;503.                        Gonzalez, V., Combe, , David, V., Malmquist, N , <br /> Besteiro, S., Michelin, , Poncet, J., Dubremetz, J.F.,             Delorme, V., Leroy, C., et al. (2009) Host cell entry   Lebrun, M. (2009) Export Toxoplasma gondii rhoptry                apicomplexa parasites requires actin polymerization   neck protein complex host cell membrane form                 host cell. Cell Host Microbe 5: 259&#226;&#8364;&#8220;272. <br />   moving junction invasion. PLoS Pathog 5:                  Gruring, C., Heiber, , Kruse, F., Ungefehr, J., Gilberger, <br />   e1000309.                                                              T.W., Spielmann, T. (2011) Development host cell <br />  <br />                           &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />                                                                                            Conditional expression PfAMA1          655 <br />   modifications Plasmodium falciparum blood stages                Narum, D.L., Thomas, W. (1994) Differential localiza- <br />   dimensions. Nat Commun 2: 165.                                      tion length processed forms PF83/AMA-1 Guerra, C , Howes, R.E., Patil, P., Gething, P.W.,                     apical membrane antigen Plasmodium falciparum <br />   Van Boeckel, T.P., Temperley, W.H., et al. (2010) inter-             merozoites. Mol Biochem Parasitol 67: 59&#226;&#8364;&#8220;68. <br />   national limits population risk Plasmodium vivax            Poukchanski, , Fritz, H.M., Tonkin, M.L., Treeck, M., <br />   transmission 2009. PLoS Negl Trop Dis 4: e774.                        Boulanger, M.J., Boothroyd, J.C. (2013) Toxoplasma <br /> Harris, K.S., Casey, J.L., Coley, M., Masciantonio, R.,                  gondii sporozoites invade host cells using novel <br />   Sabo, J.K., Keizer, D.W., et al. (2005) Binding hot spot             paralogues RON2 AMA1. PLoS 8: e70637. <br />   invasion inhibitory molecules Plasmodium falciparum                Richard, D., MacRaild, C , Riglar, D.T., Chan, J , Foley, <br />   apical membrane antigen 1. Infect Immun 73: 6981&#226;&#8364;&#8220;6989.                   M., Baum, J., et al. (2010) Interaction Plasmo- <br /> Healer, J., Murphy, V., Masciantonio, R., Hodder, N.,                    dium falciparum apical membrane antigen 1   Gemmill, W., Anders, R., et al. (2004) Allelic                         rhoptry neck protein complex defines key step   polymorphisms apical membrane antigen-1 respon-                   erythrocyte invasion process malaria parasites. J Biol <br />   sible evasion antibody-mediated inhibition Plasmo-             Chem 285: 14815&#226;&#8364;&#8220;14822. <br />   dium falciparum. Mol Microbiol 52: 159&#226;&#8364;&#8220;168.                           Riglar, D.T., Richard, D., Wilson, D.W., Boyle, M.J., <br /> Hehl, B., Lekutis, C., Grigg, M.E., Bradley, P.J., Dubremetz,            Dekiwadia, C., Turnbull, L., et al. (2011) Super-resolution <br />   J.F., Ortega-Barria, E., Boothroyd, J.C. (2000) Toxo-                dissection coordinated events malaria parasite <br />   plasma gondii homologue Plasmodium apical mem-                        invasion human erythrocyte. Cell Host Microbe 9: <br />   brane antigen 1 involved invasion host cells. Infect            9&#226;&#8364;&#8220;20. <br />   Immun 68: 7078&#226;&#8364;&#8220;7086.                                                  Sambrook, J., Fritsch, E.F., Maniatis, T. (1989) Molecular <br /> Howell, S , Withers-Martinez, C., Kocken, C.H., Thomas,                  Cloning: Laboratory Manual. Cold Spring Harbor, NY: <br />   W., Blackman, M.J. (2001) Proteolytic processing                   Cold Spring Harbor Laboratory Press, pp. 12.14&#226;&#8364;&#8220;12.29. <br />   primary structure Plasmodium falciparum apical                 Singh, S., Alam, M.M., Pal-Bhowmick, , Brzostowski, J , <br />   membrane antigen-1. J Biol Chem 276: 31311&#226;&#8364;&#8220;                              Chitnis, C.E. (2010) Distinct external signals trigger <br />   31320.                                                                   sequential release apical organelles erythrocyte <br /> Janse, C.J., Franke-Fayard, B., Mair, G.R., Ramesar, J.,                   invasion malaria parasites. PLoS Pathog 6: e1000746. <br />   Thiel, C., Engelmann, S., et al. (2006) High efficiency               Snow, R.W., Guerra, C , Noor, M., Myint, H.Y., Hay, <br />   transfection Plasmodium berghei facilitates novel selec-              S  (2005) global distribution clinical episodes   tion procedures. Mol Biochem Parasitol 145: 60&#226;&#8364;&#8220;70.                       Plasmodium falciparum malaria. Nature 434: 214&#226;&#8364;&#8220;217. <br /> Jullien, N., Sampieri, F., Enjalbert, , Herman, J.P.              Srinivasan, P., Beatty, W.L., Diouf, , Herrera, R., <br />   (2003) Regulation Cre recombinase ligand-induced                   Ambroggio, X., Moch, J.K., et al. (2011a) Binding   complementation inactive fragments. Nucleic Acids Res                 Plasmodium merozoite proteins RON2 AMA1 triggers <br />   31: e131.                                                                commitment invasion. Proc Natl Acad Sci USA 108: <br /> Lamarque, M., Besteiro, S., Papoin, J., Roques, M.,                        13275&#226;&#8364;&#8220;13280. <br />   Vulliez-Le Normand, B., Morlon-Guyot, J., et al. (2011)           Srinivasan, P., Beatty, W.L., Diouf, , Herrera, R., <br />   RON2-AMA1 interaction critical step moving                       Ambroggio, X., Moch, J.K., et al. (2011b) Binding   junction-dependent invasion apicomplexan parasites.                   Plasmodium merozoite proteins RON2 AMA1 triggers <br />   PLoS Pathog 7: e1001276.                                                 commitment invasion. Proc Natl Acad Sci USA 108: <br /> Leykauf, K., Treeck, M., Gilson, P.R., Nebl, T., Braulke, T.,              13275&#226;&#8364;&#8220;13280. <br />   Cowman, F., et al. (2010) Protein kinase dependent                Suss-Toby, E., Zimmerberg, J., Ward, G.E. (1996) Toxo- <br />   phosphorylation apical membrane antigen 1 plays                    plasma invasion: parasitophorous vacuole formed <br />   important role erythrocyte invasion malaria para-              host cell plasma membrane pinches   site. PLoS Pathog 6: e1000941.                                           fission pore. Proc Natl Acad Sci USA 93: 8413&#226;&#8364;&#8220;8418. <br /> Maier, G., Rug, M., O&#226;&#8364;&#8482;Neill, M.T., Brown, M., Chakravorty,            Thera, M , Doumbo, O.K., Coulibaly, D., Laurens, M.B., <br />   S., Szestak, T., et al. (2008) Exported proteins required            Ouattara, , Kone, K., et al. (2011) field trial assess <br />   virulence rigidity Plasmodium falciparum-infected                 blood-stage malaria vaccine. N Engl J Med 365: 1004&#226;&#8364;&#8220; <br />   human erythrocytes. Cell 134: 48&#226;&#8364;&#8220;61.                                     1013. <br /> Mital, J., Meissner, M., Soldati, D., Ward, G.E. (2005)             Tiffert, T., Lew, V.L., Ginsburg, H., Krugliak, M., Croisille, L., <br />   Conditional expression Toxoplasma gondii apical mem-                  Mohandas, N. (2005) hydration state human <br />   brane antigen-1 (TgAMA1) demonstrates TgAMA1                        red blood cells susceptibility invasion Plas- <br />   plays critical role host cell invasion. Mol Biol Cell 16:           modium falciparum. Blood 105: 4853&#226;&#8364;&#8220;4860. <br />   4341&#226;&#8364;&#8220;4349.                                                            Tonkin, M.L., Roques, M., Lamarque, M.H., Pugniere, M., <br /> Mitchell, G.H., Thomas, W., Margos, G., Dluzewski, R.,                 Douguet, D., Crawford, J., et al. (2011) Host cell invasion <br />   Bannister, L.H. (2004) Apical membrane antigen 1,                  apicomplexan parasites: insights structure <br />   major malaria vaccine candidate, mediates close                      AMA1 RON2 peptide. Science 333: 463&#226;&#8364;&#8220; <br />   attachment invasive merozoites host red blood cells.               467. <br />   Infect Immun 72: 154&#226;&#8364;&#8220;158.                                             Triglia, T., Healer, J., Caruana, S.R., Hodder, N., Anders, <br /> Montero, E., Rodriguez, M., Oksov, Y., Lobo, C  (2009)               R.F., Crabb, B.S., Cowman, F. (2000) Apical mem- <br />   Babesia divergens apical membrane antigen 1                      brane antigen 1 plays central role erythrocyte <br />   interaction human red blood cell. Infect Immun 77:              invasion Plasmodium species. Mol Microbiol 38: 706&#226;&#8364;&#8220; <br />   4783&#226;&#8364;&#8220;4793.                                                               718. <br />  <br /> &#194;&#169; 2014 Authors. Cellular Microbiology published John Wiley &amp; Sons  Cellular Microbiology, 16, 642&#226;&#8364;&#8220;656 <br />   656  Yap et al. <br /> Tyler, J.S., Boothroyd, J.C. (2011) C-terminus                induce observable growth inhibitory effect absence   Toxoplasma RON2 provides crucial link AMA1                 DiCre expression. <br />   host-associated invasion. complex. PLoS Pathog                 Fig. S3. DiCre-mediated PfAMA1 knockdown adverse <br />   7: e1001282.                                                           effects intraerythrocytic development lead invasion <br /> Vulliez-Le Normand, B., Tonkin, M.L., Lamarque, M.H.,                    inhibition. <br />   Langer, S., Hoos, S., Roques, M., et al. (2012) Structural              Synchronized W2mef/AMA1-loxP/DiCre parasites incu- <br />   functional insights malaria parasite moving               bated 0.1% DMSO v/v 0.1 &#206;&#188;M rapamycin early- <br />   junction complex. PLoS Pathog 8: e1002755.                             mid ring stage. 10, 20 35 h addition Wilson, D.W., Crabb, B.S., Beeson, J.G. (2010) Devel-                rapamycin DMSO, Giemsa smears  Parasitemia <br />   opment fluorescent Plasmodium falciparum vitro               measured proportion ring, trophozoite schizont <br />   growth inhibition assays. Malaria J 9: 152.                            stages presented fraction pie chart. time points, <br /> Wittayacom, K., Uthaipibull, C., Kumpornsin, K., Tinikul, R.,            proportion ring, trophozoite schizont stages compa- <br />   Kochakarn, T., Songprakhon, P., Chookajorn, T. (2010)              rable treatments. <br />   nuclear targeting Plasmodium falciparum.                   B. Closer inspection parasite growth reinvasion using <br />   Malaria J 9: 126.                                                      SYBR Green  DMSO-treated parasites displayed normal growth <br />                                                                          phenotype majority ring-stage parasites day 0 <br />                                                                          progressed late-stage parasites day 1. day 2, majority <br />                                                                          late-stage parasites reinvaded form new ring-stage <br /> Supporting information                                                   parasites resulting doubling total parasitemia. Total <br />                                                                          parasitemia higher samples processed later Additional Supporting Information online <br />                                                                          late-stages egressed reinvaded. Parasites <br /> version article publisher&#226;&#8364;&#8482;s web-site: <br />                                                                          split roughly 1:2  days 2 3) 1:3  Fig. S1. Southern blot analysis W2mef/AMA1-loxP parasite              days 4 5) denoted vertical dashed lines. repre- <br /> clones. clones isolated, seven tandem               sentative sample triplicate experiment shown. <br /> pAMA1-loxP plasmids integrated Pfama1 gene locus                C. Rapamycin-treated parasites displayed normal intraery- <br /> resulting copies 3D7 Pfama1 gene inserted. Clone           throcytic growth failed invade normally. expected, #3 selected subsequent transfection pDiCre.                   ringstage parasites day 0 progressed late-stages Fig. S2. Identifying optimal rapamycin concentration efficient       day 1 confirming rapamycin does adversely <br /> DiCre activation target toxicity effects.                    affect parasite growth. days <br /> </body></html>